These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3259 related articles for article (PubMed ID: 24119843)

  • 1. Super-enhancers in the control of cell identity and disease.
    Hnisz D; Abraham BJ; Lee TI; Lau A; Saint-André V; Sigova AA; Hoke HA; Young RA
    Cell; 2013 Nov; 155(4):934-47. PubMed ID: 24119843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Master transcription factors and mediator establish super-enhancers at key cell identity genes.
    Whyte WA; Orlando DA; Hnisz D; Abraham BJ; Lin CY; Kagey MH; Rahl PB; Lee TI; Young RA
    Cell; 2013 Apr; 153(2):307-19. PubMed ID: 23582322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What are super-enhancers?
    Pott S; Lieb JD
    Nat Genet; 2015 Jan; 47(1):8-12. PubMed ID: 25547603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Convergence of developmental and oncogenic signaling pathways at transcriptional super-enhancers.
    Hnisz D; Schuijers J; Lin CY; Weintraub AS; Abraham BJ; Lee TI; Bradner JE; Young RA
    Mol Cell; 2015 Apr; 58(2):362-70. PubMed ID: 25801169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide identification and characterisation of HOT regions in the human genome.
    Li H; Liu F; Ren C; Bo X; Shu W
    BMC Genomics; 2016 Sep; 17(1):733. PubMed ID: 27633377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancer RNAs: a missing regulatory layer in gene transcription.
    Mao R; Wu Y; Ming Y; Xu Y; Wang S; Chen X; Wang X; Fan Y
    Sci China Life Sci; 2019 Jul; 62(7):905-912. PubMed ID: 30593613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative modeling reveals key chromatin and sequence signatures predicting super-enhancers.
    Khan A; Zhang X
    Sci Rep; 2019 Feb; 9(1):2877. PubMed ID: 30814546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular understanding of super-enhancer dysregulation in cancer.
    Yoshino S; Suzuki HI
    Nagoya J Med Sci; 2022 May; 84(2):216-229. PubMed ID: 35967935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal identity genes regulated by super-enhancers are preferentially down-regulated in the striatum of Huntington's disease mice.
    Achour M; Le Gras S; Keime C; Parmentier F; Lejeune FX; Boutillier AL; Néri C; Davidson I; Merienne K
    Hum Mol Genet; 2015 Jun; 24(12):3481-96. PubMed ID: 25784504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of tumor oncogenes by disruption of super-enhancers.
    Lovén J; Hoke HA; Lin CY; Lau A; Orlando DA; Vakoc CR; Bradner JE; Lee TI; Young RA
    Cell; 2013 Apr; 153(2):320-34. PubMed ID: 23582323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic super-enhancers in cancer: mechanisms and therapeutic targets.
    Bacabac M; Xu W
    Cancer Metastasis Rev; 2023 Jun; 42(2):471-480. PubMed ID: 37059907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Super-Enhancer-Mediated RNA Processing Revealed by Integrative MicroRNA Network Analysis.
    Suzuki HI; Young RA; Sharp PA
    Cell; 2017 Mar; 168(6):1000-1014.e15. PubMed ID: 28283057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Super-enhancers are transcriptionally more active and cell type-specific than stretch enhancers.
    Khan A; Mathelier A; Zhang X
    Epigenetics; 2018; 13(9):910-922. PubMed ID: 30169995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The RNA Pol II elongation factor Ell3 marks enhancers in ES cells and primes future gene activation.
    Lin C; Garruss AS; Luo Z; Guo F; Shilatifard A
    Cell; 2013 Jan; 152(1-2):144-56. PubMed ID: 23273992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Super-enhancers in cancer.
    Thandapani P
    Pharmacol Ther; 2019 Jul; 199():129-138. PubMed ID: 30885876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancers in embryonic stem cells are enriched for transposable elements and genetic variations associated with cancers.
    Teng L; Firpi HA; Tan K
    Nucleic Acids Res; 2011 Sep; 39(17):7371-9. PubMed ID: 21685454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Super-Enhancer-Associated Oncogenes in Osteosarcoma with THZ2, a Covalent CDK7 Inhibitor.
    Zhang J; Liu W; Zou C; Zhao Z; Lai Y; Shi Z; Xie X; Huang G; Wang Y; Zhang X; Fan Z; Su Q; Yin J; Shen J
    Clin Cancer Res; 2020 Jun; 26(11):2681-2692. PubMed ID: 31937612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancers and super-enhancers have an equivalent regulatory role in embryonic stem cells through regulation of single or multiple genes.
    Moorthy SD; Davidson S; Shchuka VM; Singh G; Malek-Gilani N; Langroudi L; Martchenko A; So V; Macpherson NN; Mitchell JA
    Genome Res; 2017 Feb; 27(2):246-258. PubMed ID: 27895109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Research progress of super enhancer in cancer].
    Wu ZQ; Mi ZY
    Yi Chuan; 2019 Jan; 41(1):41-51. PubMed ID: 30686784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation-sensitive super enhancers form domains of coordinately regulated enhancer RNAs.
    Hah N; Benner C; Chong LW; Yu RT; Downes M; Evans RM
    Proc Natl Acad Sci U S A; 2015 Jan; 112(3):E297-302. PubMed ID: 25564661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 163.